|
Study Participants |
||
| Niacin (n = 33) |
Placebo (n = 35) |
|
|
|
||
| Age, years, mean (SD) |
27.2 (5.23) |
26.4 (3.32) |
| Sex: Male |
7 |
10 |
| Female |
26 |
25 |
| Weight, kg, mean (SD) |
64.05 (11.15) |
64.7 (11.29) |
| Ethnicity: |
||
| Caucasian |
24 |
24 |
| Black |
1 |
1 |
| Middle Eastern |
0 |
2 |
| Hispanic |
1 |
1 |
| East Asian |
5 |
5 |
| South Asian |
2 |
2 |
|
SD, standard deviation | ||
Mills et al. BMC Clinical Pharmacology 2003 3:4 doi:10.1186/1472-6904-3-4 |
||